Cargando…
Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice
Muscular dystrophy-dystroglycanopathies (MDDGs) resulting from fukutin-related protein (FKRP) gene mutations are rare disorders that result in a wide spectrum of clinical severity based on the age of onset, the degree of myogenic atrophy, and/or neurologic involvement. There is no cure for any of th...
Autores principales: | Vannoy, Charles Harvey, Leroy, Victoria, Lu, Qi Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222079/ https://www.ncbi.nlm.nih.gov/pubmed/30417025 http://dx.doi.org/10.1016/j.omtm.2018.10.004 |
Ejemplares similares
-
Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene
por: Vannoy, Charles Harvey, et al.
Publicado: (2017) -
Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice Indicates Improvement After Gene Replacement Therapy
por: Vannoy, Charles Harvey, et al.
Publicado: (2019) -
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019) -
Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice
por: Tucker, Jason D., et al.
Publicado: (2018) -
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
por: Cataldi, Marcela P., et al.
Publicado: (2018)